Related Experiment Videos
Research activity at the Max Planck Institute for Psychiatry (Munich): depression in later life
1Max Planck Institute for Psychiatry, Clinical Institute, Munich, Germany.
International Psychogeriatrics
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51.
Cell death and differentiation·2016
SLC6A15, a novel stress vulnerability candidate, modulates anxiety and depressive-like behavior: involvement of the glutamatergic system.
Stress (Amsterdam, Netherlands)·2015
Evidence for the role of corticotropin-releasing factor in major depressive disorder.
Neuroscience and biobehavioral reviews·2015
Genetics of rapid eye movement sleep in humans.
Translational psychiatry·2015
Caregiving dyad typologies and trajectories of care partner burden following hospitalization in persons living with dementia.
International psychogeriatrics·2026
Memantine in Korean Alzheimer's disease: A prospective real-world REMIND study.
International psychogeriatrics·2026
Spouse-side heterogeneity in widowhood: Preloss cognitive performance and survivors' depressive-symptom change.
International psychogeriatrics·2026
The SOAR project: Developing a framework for screening for older adults' abuse risk.
International psychogeriatrics·2026
Is wisdom a predictor of quality of life in people with experience of dementia?
International psychogeriatrics·2026
Ketamine administered biomedically or as psychedelic-assisted therapy in treatment-resistant depression: Differing efficacy based on depressive subtype or presence of childhood trauma?
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Attention-Deficit/Hyperactivity Disorder as a Risk Factor for Suicidality in Patients With Borderline Personality Disorder.
Journal of personality disorders·2026